[Invasive Mold Infections in Patients with Hematologic Malignities: The Effects of Environmental Factors].

Hematolojik Maligniteli Hastalarda İnvaziv Küf Enfeksiyonları: Çevresel Faktörlerin Etkisi.

Journal

Mikrobiyoloji bulteni
ISSN: 0374-9096
Titre abrégé: Mikrobiyol Bul
Pays: Turkey
ID NLM: 7503830

Informations de publication

Date de publication:
Apr 2022
Historique:
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 30 4 2022
Statut: ppublish

Résumé

Invasive fungal infections (IFI) continue to be an important cause of morbidity and mortality in patients with hematological malignancies. Candida and Aspergillus species constitute most of the IFI in these patients.. It has been reported that most of the invasive aspergillosis epidemics are related to the construction works in the hospital. In this study, we aimed to investigate the frequency of IFI in the old and the new hospital building after relocation in patients with hematological malignancies. Of 8042 patients who were hospitalized in the Department of Hematology, Ondokuz Mayıs University Faculty of Medicine between January 2015 and September 2019, 412 patients who were initiated antifungal therapy were included in the study. The patients in the hematology clinic, which were moved to the new oncology hospital building in January 2018, were grouped as prior and after relocation, and their demographical data, hematological diagnosis, chemotherapy regimens, mortality, IFI, focus of infection, presence of central venous catheter, antifungal prophylaxis and treatment, galactomannan level, fungal culture and computed tomography (CT) findings were evaluated retrospectively. It was determined that 55% of the patients were male and the median age was 58 (range:18-93). The rate of IFI development was 5.12% (n= 412) and the rate of invasive mold infection was 1.2% (n= 145). The most common hematological disease for which antifungal treatment initiated was acute myeloid leukemia (AML) with a rate of 50% (n= 206/412). Of patients, 73% received induction chemotherapy (42%, first induction, 31% reinduction), 13.4% received consolidation therapy. Invasive mold infection was diagnosed as 40% possible, 59% probable, 1% proven. While patients had similar characteristics such as age, gender, hematological disease, chemotherapy regimens and antifungal prophylaxis prior and after transportation, the rate of development of invasive mold infection was 2.1%, 2.06 / 1000 patient days, before transportation, 1.37% (p= 0.009), 1.15/1000 patient days (p<0.001) after transportation, and it was statistically significantly lower after transportation. The median value of galactomannan antigen was detected as 0.17 (0.02-5.9). Blood cultures revealed 10.3% fungal growth and the most common growth was Candida albicans with 54.8% and Mucor spp. as mold with 3.2%. Large-scale construction works such as renovation, extension and demolition works in old hospital buildings are a permanent condition in different units. Clinicians should be aware of that infections due to opportunistic fungi can be seen in immunosuppressive patients close to such construction sites, and even cause epidemics. It should be kept in mind that these infections, which can progress with serious morbidity and mortality are difficult to treat but can be prevented by infection control measures.

Identifiants

pubmed: 35477233
doi: 10.5578/mb.20229810
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

tur

Sous-ensembles de citation

IM

Pagination

315-325

Auteurs

Aynur Atilla (A)

Ondokuz Mayıs University Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Samsun, Turkey.

Merve Çelik (M)

Ondokuz Mayıs University Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Samsun, Turkey.

Özkul Yılmaz Çolak (ÖY)

Ondokuz Mayıs University Faculty of Medicine, Division of Hematology, Samsun, Turkey.

Tuba Kuruoğlu (T)

Ondokuz Mayıs University Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Samsun, Turkey.

Fatih Temoçin (F)

Ondokuz Mayıs University Faculty of Medicine, Department of Infectious Disease and Clinical Microbiology, Samsun, Turkey.

Engin Kelkitli (E)

Ondokuz Mayıs University Faculty of Medicine, Division of Hematology, Samsun, Turkey.

Asuman Birinci (A)

Ondokuz Mayıs University Faculty of Medicine, Department of Medical Microbiology, Samsun, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH